Welcome to our dedicated page for Xylem SEC filings (Ticker: XYL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xylem Inc. (NYSE: XYL) is a Fortune 500 global water solutions company that reports its financial and operational information to the U.S. Securities and Exchange Commission. The XYL SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, along with AI-powered tools that help explain the content and context of each document.
Among the key filings for Xylem are its Form 10-K annual reports, which typically include a comprehensive discussion of the business, risk factors, and financial statements, and Form 10-Q quarterly reports, which update investors on revenue, margins, cash flows, and segment performance. For example, Xylem’s third-quarter 2025 results were furnished to the SEC via a Form 8-K that referenced its earnings press release and discussed revenue from products and services, adjusted earnings per share, and adjusted EBITDA margin.
The company also files Form 8-K current reports to announce material events such as quarterly results, portfolio transactions, and other significant developments. Recent 8-K filings have covered financial results for quarters ended June 30 and September 30, 2025, with exhibits that include the full text of related press releases.
On this page, users can review Xylem’s historical and ongoing SEC submissions, including annual and quarterly reports, current reports, and other required documents. Stock Titan’s AI-generated summaries highlight important sections, clarify technical language, and point out items that may be relevant to investors, such as segment commentary, outlook statements, and references to restructuring or portfolio optimization.
In addition, the filings page can surface insider transaction reports (Form 4) and proxy-related disclosures when available, helping users monitor equity awards, share ownership changes, and governance matters. Real-time updates from EDGAR combined with AI analysis make it easier to navigate Xylem’s filings and understand how the company communicates its financial condition, risks, and strategic priorities to regulators and the market.
Xylem Inc. (XYL) furnished a current report announcing it issued a press release with financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1.
The information is designated as “furnished,” not “filed,” under Section 18 of the Exchange Act and is incorporated by reference only if specifically noted in a future filing.
Xylem Inc. (XYL) insider filing: EVP & Pres, AW Meredith Emmerich reported a tax withholding transaction tied to RSU vesting. On 10/21/2025, 841 shares of common stock were withheld to cover taxes at a reported price of $147.19 (Transaction Code F).
Following this withholding, the reporting person directly beneficially owns 3,992 shares. The RSUs vested from an award granted on October 21, 2024 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
Xylem Inc. insider William K. Grogan had 4,254 shares of common stock withheld at a price of $142.18 on 09/18/2025 to cover taxes arising from the vesting of restricted stock units granted on 09/18/2023 under the Xylem 2011 Omnibus Incentive Plan. After the withholding, Grogan beneficially owns 28,199 shares, which figure also reflects additional shares from dividend reinvestment. The Form 4 was filed by one reporting person and executed by an attorney-in-fact on behalf of Mr. Grogan.
Geri-Michelle McShane, Vice President and Chief Accounting Officer of Xylem Inc. (XYL), reported a sale of 1,000 shares of Xylem common stock on 09/05/2025 at a weighted-average price of $139.962 per share (executed in a price range of $139.96–$139.98). After the transaction, the reporting person beneficially owned 2,957 shares of Xylem common stock. The Form 4 was signed by a power of attorney on behalf of the reporting person.
Xylem Inc. (XYL) Form 144 notifies a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $139,962. The filing lists the issuer's outstanding common shares as 243,409,688, and shows an approximate sale date of 09/05/2025. The shares reported were acquired primarily via the company's Employee Stock Purchase Plan in multiple small purchases between 03/23/2023 and 03/01/2024, with the largest single acquisition entries totaling 477, 322, and 136 shares.
The notice contains no reportable sales in the past three months and includes the standard representation that the seller is unaware of undisclosed material adverse information about the issuer.
Stacy Cozad, SVP & Chief Legal Officer of Xylem Inc. (XYL), received equity awards on 09/02/2025. The filing reports 735 restricted stock units granted at an indicated price of $140.35 and 2,579 non-qualified stock options$140.35. The RSUs and options vest in three equal annual tranches on March 5, 2026, 2027 and 2028. After these transactions the filing shows 735 shares2,579 option-related shares
Insider sale by Xylem director. A director of Xylem Inc. reported selling 4,900 shares of the company's common stock on 08/18/2025 at a weighted average price of $140.6594 per share. After the sale the reporting person beneficially owns 5,163 shares. The filing discloses that the 4,900 shares were sold across a price range of $140.43 to $140.86 and that the reporting person will provide details of the number of shares sold at each price upon request.
Form 144 filed for Xylem Inc. (XYL) reporting a proposed sale of 4,900 shares of common stock through Goldman Sachs & Co. LLC on 08/18/2025. The filing lists an aggregate market value of $690,165 and indicates 243,409,688 shares outstanding for the issuer. The shares to be sold were acquired as restricted stock units (compensation) on multiple dates between 02/16/2023 and 05/12/2025, in lots of 915, 1187, 1633, 3, 7 and 1155 shares respectively. The filer attests they are not aware of undisclosed material adverse information about the issuer. No sales in the past three months were reported.
Stacy Cozad, serving as SVP & Chief Legal Officer and an officer/director of Xylem Inc. (XYL), filed an Initial Form 3 reporting the event dated 08/13/2025. The filing states no securities are beneficially owned by the reporting person as of the filing date. The form was signed by an attorney-in-fact and confirms compliance with Section 16 reporting requirements.